EP2677886A4 - Substrats indirects pour des microorganismes dont le métabolisme produit du propane-1,2-diol - Google Patents

Substrats indirects pour des microorganismes dont le métabolisme produit du propane-1,2-diol

Info

Publication number
EP2677886A4
EP2677886A4 EP12749453.2A EP12749453A EP2677886A4 EP 2677886 A4 EP2677886 A4 EP 2677886A4 EP 12749453 A EP12749453 A EP 12749453A EP 2677886 A4 EP2677886 A4 EP 2677886A4
Authority
EP
European Patent Office
Prior art keywords
propanediol
microorganisms metabolizing
indirect substrates
indirect
substrates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP12749453.2A
Other languages
German (de)
English (en)
Other versions
EP2677886A1 (fr
Inventor
Stefan Roos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biogaia AB
Original Assignee
Biogaia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/400,735 external-priority patent/US20120263696A1/en
Application filed by Biogaia AB filed Critical Biogaia AB
Publication of EP2677886A1 publication Critical patent/EP2677886A1/fr
Publication of EP2677886A4 publication Critical patent/EP2677886A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/22—Processes using, or culture media containing, cellulose or hydrolysates thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/231—Pectin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732—Pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Dispersion Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP12749453.2A 2011-02-23 2012-02-23 Substrats indirects pour des microorganismes dont le métabolisme produit du propane-1,2-diol Withdrawn EP2677886A4 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161463846P 2011-02-23 2011-02-23
US201161517130P 2011-04-14 2011-04-14
US13/400,735 US20120263696A1 (en) 2011-04-14 2012-02-21 Indirect Substrates for Microorganisms Metabolizing 1,2-Propanediol
PCT/SE2012/050202 WO2012115588A1 (fr) 2011-02-23 2012-02-23 Substrats indirects pour des microorganismes dont le métabolisme produit du propane-1,2-diol

Publications (2)

Publication Number Publication Date
EP2677886A1 EP2677886A1 (fr) 2014-01-01
EP2677886A4 true EP2677886A4 (fr) 2015-09-02

Family

ID=48782680

Family Applications (1)

Application Number Title Priority Date Filing Date
EP12749453.2A Withdrawn EP2677886A4 (fr) 2011-02-23 2012-02-23 Substrats indirects pour des microorganismes dont le métabolisme produit du propane-1,2-diol

Country Status (12)

Country Link
EP (1) EP2677886A4 (fr)
JP (1) JP2014513058A (fr)
KR (1) KR20130140812A (fr)
CN (1) CN103402377A (fr)
AU (1) AU2012221154B2 (fr)
BR (1) BR112013020695A2 (fr)
CA (1) CA2828072A1 (fr)
MX (1) MX2013009650A (fr)
RU (1) RU2013142920A (fr)
SG (1) SG191355A1 (fr)
WO (1) WO2012115588A1 (fr)
ZA (1) ZA201304704B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220211732A1 (en) * 2019-05-23 2022-07-07 Evonik Operations Gmbh Prebiotic compositions
EP4056052A1 (fr) * 2021-03-12 2022-09-14 Biogaia AB Préconditionnement gos de l. reuteri et gos dans une formulation finale
EP4056053A1 (fr) * 2021-03-12 2022-09-14 Biogaia AB Préconditionnement de l. reuteri

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3587219B2 (ja) * 1995-04-20 2004-11-10 アサマ化成株式会社 食品用保存剤
WO2009151391A1 (fr) * 2008-06-10 2009-12-17 Biogaia Ab Activation contrôlée du mécanisme de production de reutérine de lactobacillus reuteri
EP2143341A1 (fr) * 2008-07-08 2010-01-13 Nestec S.A. Composition nutritionnelle contenant un mélange d'oligosaccharides

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2320883A (en) * 1996-01-05 1998-07-08 Hyprotech Treatment of soya beans
DE19836339B4 (de) * 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
EP1446023B1 (fr) * 2001-11-12 2009-02-25 Mars, Incorporated Aliments pour chats et chiens
AU2003250503A1 (en) * 2002-06-13 2003-12-31 University College Cork - National University Of Ireland, Cork Probiotic therapies using lactobacillus reuteri
FR2844453B1 (fr) * 2002-09-13 2006-05-19 Agronomique Inst Nat Rech Utilisation de pre-biotiques pour la prevention de l'installation du diabete de type ii
DE602006017423D1 (de) * 2005-11-14 2010-11-18 Unilever Nv Essbares produkt, das ginseng-polysaccharide und gesunde bakterien enthält
NL1033521C2 (nl) * 2007-03-08 2008-09-09 Friesland Brands Bv Kindervoedingen met geoptimaliseerde aminozuursamenstelling.
CN102202527B (zh) * 2008-11-03 2014-12-31 雀巢产品技术援助有限公司 包含益生菌并改善睡眠模式的营养组合物
ATE489856T1 (de) * 2009-01-06 2010-12-15 Rosebud Ag Symbiotische zusammensetzung und ihr herstellungsverfahren
AU2010281534B2 (en) * 2009-07-27 2014-10-16 Société des Produits Nestlé S.A. Nutritional compositions comprising fiber and probiotics
CN101671399B (zh) * 2009-10-10 2011-05-11 山东大学威海分校 一种高纯度高硫酸根岩藻聚糖硫酸酯的制备方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3587219B2 (ja) * 1995-04-20 2004-11-10 アサマ化成株式会社 食品用保存剤
WO2009151391A1 (fr) * 2008-06-10 2009-12-17 Biogaia Ab Activation contrôlée du mécanisme de production de reutérine de lactobacillus reuteri
EP2143341A1 (fr) * 2008-07-08 2010-01-13 Nestec S.A. Composition nutritionnelle contenant un mélange d'oligosaccharides

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHERYL A. KERFELD ET AL: "Bacterial Microcompartments", ANNUAL REVIEW OF MICROBIOLOGY, vol. 64, no. 1, 13 October 2010 (2010-10-13), pages 391 - 408, XP055201028, ISSN: 0066-4227, DOI: 10.1146/annurev.micro.112408.134211 *
J. XUE ET AL: "Exogenous or L-Rhamnose-Derived 1,2-Propanediol Is Metabolized via a pduD-Dependent Pathway in Listeria innocua", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, vol. 74, no. 22, 15 November 2008 (2008-11-15), pages 7073 - 7079, XP055200994, ISSN: 0099-2240, DOI: 10.1128/AEM.01074-08 *
See also references of WO2012115588A1 *
SRIRAMULU D D ET AL: "Lactobacillus reuteri DSM 20016 produces cobalamin-dependant diol dehydratase in metabolosomes and metabolizes 1,2-propanediol by disproportionation", JOURNAL OF BACTERIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 190, no. 13, 1 July 2008 (2008-07-01), pages 4559 - 4567, XP003025600, ISSN: 0021-9193, DOI: 10.1128/JB.01535-07 *

Also Published As

Publication number Publication date
SG191355A1 (en) 2013-08-30
BR112013020695A2 (pt) 2016-10-25
WO2012115588A1 (fr) 2012-08-30
NZ613318A (en) 2015-10-30
JP2014513058A (ja) 2014-05-29
CN103402377A (zh) 2013-11-20
AU2012221154B2 (en) 2015-12-10
RU2013142920A (ru) 2015-03-27
KR20130140812A (ko) 2013-12-24
EP2677886A1 (fr) 2014-01-01
ZA201304704B (en) 2014-09-25
AU2012221154A1 (en) 2013-07-18
MX2013009650A (es) 2013-09-26
CA2828072A1 (fr) 2012-08-30

Similar Documents

Publication Publication Date Title
EP2670820A2 (fr) Procédé de traitement des hydrocarbures
GB201100114D0 (en) Determing positiion
PL2711350T3 (pl) Sposób wytwarzania 1,3-butadienu
PL2760811T3 (pl) Sposób wytwarzania 2,3,3,3-tetrafluoropropenu
IL231352A0 (en) New enzyme inhibitory compounds
IL231353A0 (en) New enzyme inhibitory compounds
EP2675773A4 (fr) Procédé de préparation de cis-1-chloro-3,3,3-trifluoropropène
IL228546A0 (en) fermentation process
EP2668175A1 (fr) Procédé
GB201112231D0 (en) Micro-organism
IL227975A0 (en) 4-aryl-n-phenyl-5,3,1-triazine-2-converted amines
SG11201403280PA (en) Bioreactor
EP2687519A4 (fr) Procédé de production de composés 1,2-benzisothiazol-3-one
GB2510069B (en) Drive carrier substrate
PL2809161T3 (pl) Sposób biologicznego zwalczania pseudomonas
ZA201304704B (en) Indirect substrates for microorganisms metabolizing 1,2-propanediol
IL230159A0 (en) Method for the production of 2-amino-5-cyano-n,3-dimethylbenzamide
IL232630A0 (en) A method for the preparation of 6,2-difluoroacetophenones
PL2739721T3 (pl) Pożywka
EP2479518B8 (fr) Installation de réfrigération à plusieurs utilisateurs
GB201112812D0 (en) Preventing anaerobic corrosion
GB201105537D0 (en) New process
GB201021650D0 (en) Longer, straighter drive 2
IL232311A0 (en) Process for the production of 4-hydroxymethyl-2,3,5,6-tetrafluorotoluene
GB201121295D0 (en) Microorganisms

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20130920

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

RA4 Supplementary search report drawn up and despatched (corrected)

Effective date: 20150730

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 35/747 20150101ALI20150724BHEP

Ipc: A23L 1/30 20060101AFI20150724BHEP

Ipc: A23L 1/308 20060101ALI20150724BHEP

Ipc: A61K 31/7004 20060101ALI20150724BHEP

Ipc: A61K 31/732 20060101ALI20150724BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20170901

RIC1 Information provided on ipc code assigned before grant

Ipc: A23L 1/308 20181130ALI20150724BHEP

Ipc: A61K 35/747 20150101ALI20150724BHEP

Ipc: A61K 31/7004 20060101ALI20150724BHEP

Ipc: A61K 31/732 20060101ALI20150724BHEP

Ipc: A23L 1/30 20181130AFI20150724BHEP

RIC1 Information provided on ipc code assigned before grant

Ipc: A23L 1/308 20060101ALI20150724BHEP

Ipc: A23L 1/30 20060101AFI20150724BHEP

Ipc: A61K 31/7004 20060101ALI20150724BHEP

Ipc: A61K 31/732 20060101ALI20150724BHEP

Ipc: A61K 35/747 20150101ALI20150724BHEP